Purchase Order 75N91020P00546
Award Date 7/1/20
Potential Completion Date 6/30/25
Potential Value $336K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance services on a government-owned Illumina NovaSeq 6000 sequencing instrument. The $134,247.36 contract provides annual preventive maintenance, emergency repair, software/firmware updates, replacement parts, and technical support for the sequencing system located at the NCI's Laboratory of Pathology in Bethesda,...
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services (HHS), to Illumina, Inc. for maintenance services on Illumina HiScan, MiSeq, and cBot equipment. The contract has a ceiling value of $112,799.09 and runs through March 8, 2023. There is no set-aside designation for this award. Through past prime federal contracts, Illumina has provided sequencing systems, reagents, and other products and...
- This is a $142,990 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract has no set-aside designation. Illumina has previously received prime federal contract awards from other agencies like the CDC, USDA, and VA to provide sequencing systems, reagents, and related services in support of genomics...
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc. for the procurement of one (1) genetic analyzer in Bethesda, Maryland. The total award value is $95,931.00 and the ultimate completion date is July 6, 2017. No set-aside designation was used. Illumina, Inc. is a manufacturer of sequencing and array-based genomic analysis instruments and reagents, and has a...
- The National Cancer Institute awarded a purchase order to Illumina, Inc. for maintenance and service of government-owned Illumina sequencing platforms and ancillary equipment, with a ceiling value of $1,042,524.31 and an award date of May 8, 2026. Work is performed at Bethesda, Maryland. The order covers on-site maintenance services for NextSeq 2000, NextSeq 550Dx, iScan, and related devices in accordance with Original Equipment Manufacturer standards, including replacement parts and software...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $35,410.00, is for the maintenance of lab equipment. Illumina, a for-profit manufacturer of goods, has been a significant provider of advanced DNA...
- This is a firm fixed price delivery order awarded by the National Cancer Institute, an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for $3,689.79. Illumina, a manufacturer of genome sequencing and analysis instruments and reagents, will provide its proprietary sequencing systems, consumables, and support services to the agency. This order is part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the...
- This is a $145,853.00 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Illumina, Inc. The contract is for a maintenance agreement for scientific equipment, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems and related reagents and consumables. Illumina is a for-profit manufacturer that has provided a range of genomic sequencing and analysis products and services...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $130,847 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The purpose is to procure preventive maintenance services for a government-owned Illumina NovaSeq 6000 Sequencing System located at the National Cancer Institute in Bethesda, Maryland. The Laboratory of Pathology requires these services to maintain optimal instrument operation, generate comparable...